Literature DB >> 9023058

Chemokine-leukocyte interactions. The voodoo that they do so well.

D D Taub1.   

Abstract

Leukocyte recruitment from the circulation into inflammatory tissues requires a series of soluble and cell-bound signals between the responding leukocyte and vascular endothelial barrier. Chemotactic factors are believed to be responsible for this selective adhesion and transmigration. A superfamily of small, soluble, structurally-related molecules called 'chemokines' have been identified and shown to selectively promote the rapid adhesion and chemotaxis of a variety of leukocyte subtypes both in vivo and in vitro. Chemokines are produced by almost every cell type in the body in response to a number of inflammatory signals, in particular those which activate leukocyte-endothelial cell interactions. These molecules also appear to play important roles in hematopoesis, cellular activation, and leukocyte effector functions. In addition, chemokines have been found in the tissues of a variety of disease states characterized by distinct leukocytic infiltrates, including rheumatoid arthritis, sepsis, atherosclerosis, asthma, psoriasis, ischemia/reperfusion injury, HIV replication, and a variety of pulmonary disease states. This review will primarily focus on the role of chemokines in cell adhesion and trafficking as well as their role as effector molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9023058     DOI: 10.1016/s1359-6101(97)89237-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  30 in total

1.  Elevated chemokine responses are maintained in lungs after clearance of viral infection.

Authors:  Jason B Weinberg; Mary L Lutzke; Stacey Efstathiou; Steven L Kunkel; Rosemary Rochford
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Expression of macrophage inflammatory protein-1alpha in Kupffer cells following liver ischemia or reperfusion injury in rats.

Authors:  Wei Ma; Zuo-Ren Wang; Lei Shi; Yue Yuan
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.

Authors:  U F Power; T Huss; V Michaud; H Plotnicky-Gilquin; J Y Bonnefoy; T N Nguyen
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function.

Authors:  Edgardo Laborde; Robert W Macsata; Fanying Meng; Brian T Peterson; Louise Robinson; Steve R Schow; Reyna J Simon; Hua Xu; Kunihisa Baba; Hideaki Inagaki; Yoshiro Ishiwata; Takahito Jomori; Yukiharu Matsumoto; Atsushi Miyachi; Takashi Nakamura; Masayuki Okamoto; Tracy M Handel; Claude C A Bernard
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

Review 5.  Chemokines in the inflammatory bowel diseases.

Authors:  R P MacDermott
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

6.  Gammaherpesvirus-induced lung pathology is altered in the absence of macrophages.

Authors:  J M Cadillac; R E Sigler; J B Weinberg; M L Lutzke; R Rochford
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

7.  The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.

Authors:  P Menten; S Struyf; E Schutyser; A Wuyts; E De Clercq; D Schols; P Proost; J Van Damme
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis.

Authors:  Markus Entleutner; Tobias Traeger; Alexandra Westerholt; Bernhard Holzmann; Albrecht Stier; Klaus Pfeffer; Stefan Maier; Claus-Dieter Heidecke
Journal:  Int J Colorectal Dis       Date:  2005-03-09       Impact factor: 2.571

9.  Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein.

Authors:  R Mahieux; P F Lambert; E Agbottah; M A Halanski; L Deng; F Kashanchi; J N Brady
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.